Oregon
The Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the February 18 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
Also in Oregon, the PDAB published its quarterly newsletter for January 2026. Past editions are available online.
Also in Oregon, the Oregon Health Authority (OHA) published a temporary rule adopting the new version of the High-Cost Drug Carve-Out (HCDCO) List effective February 1. In September 2025, OHA leadership and the Governor’s office agreed to implement a number of changes effective January 2026 that would reduce costs and administrative burden for coordinated care organizations (CCOs). Starting January 1, 2026, select high-cost drugs are carved out from CCO capitation. This is referred to as the High-Cost Drug Carve-Out (HCDCO). OHA reviews prior authorization (PA) requests for HCDCO products. Approved treatments will be covered by OHA directly on a fee-for-service (FFS) basis according to FFS reimbursement rules. CCOs are responsible for everything else, including care coordination, drug administration, inpatient stays, transportation, etc. There are 47 drugs on the initial HCDCO List. They all have a high cost ($500k or more per member per year) and treat a rare condition that has few, if any, other treatment alternatives. New drugs requested for review may be added to the HCDCO List up to four times a year following the rulemaking process if they meet these criteria.
Finally in Oregon, the Department of Human Services announced a new resource to help promote food resources across the state. Individuals may visit NeedFood.Oregon.gov to find food resources near them.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
